Objective-Circulating angiogenic cells (CACs) participate in neovascularization and arterial repair. Although highdensity lipoprotein (HDL) is known to enhance the functional activity of CACs, the mechanisms underlying this regulation are poorly understood. Here, we examined the mechanism(s) by which reconstituted HDL (rHDL) affects CAC senescence. Methods and Results-CACs isolated from human peripheral blood and treated with rHDL displayed reduced senescence, as measured by acidic ␤-galactosidase staining. This protective effect was blocked by the mammalian target of rapamycin (mTOR) inhibitor (rapamycin). According to Western blot analysis and immunoprecipitation results, rHDL promoted mTOR phosphorylation, mTOR-rictor complex formation, and mTOR-rictor-dependent Akt activation, which were accompanied by increased nuclear translocation of human telomerase reverse transcriptase and enhanced nuclear telomerase activity. Suppression of rictor gene expression with a small interfering RNA blocked mTOR-rictor complex formation and Akt activation. The suppression also abolished the rHDL-induced inhibition of CAC senescence and promotion of nuclear telomerase activity. Treatment of aged mice with rHDL attenuated spleen-derived CAC senescence. In CACs isolated from rHDL-treated aged mice, the phosphorylated mTOR and Akt levels were significantly enhanced. Conclusion-rHDL stimulates sustained mTOR phosphorylation and mTOR-rictor complex formation and inhibits senescence onset in CACs through mTOR complex 2 pathway activation. (Arterioscler Thromb Vasc Biol. 2011;31:1421-1429.) 
C irculating angiogenic cells (CACs) play important roles in ischemic neovascularization and arterial injury repair through their secretion of proangiogenic factors. 1, 2 Increased CAC activity and quantities are beneficial for arterial endothelial function and angiogenesis in ischemic tissues. Conversely, functional impairment of CACs (eg, through enhanced senescence) may underlie atherogenesis and other cardiovascular events. [3] [4] [5] There is evidence that high-density lipoprotein (HDL) levels are inversely correlated with ischemic heart disease incidence, in part through their protection against atherosclerotic cardiovascular disease and their promotion of ischemic neovascularization by improving endothelial progenitor cell (EPC) levels and functionality. 6 Although CACs were once considered to be a subpopulation of heterogeneous EPCs (designated "early EPCs"), more recently CACs have been regarded as a distinct CD133 ϩ KDR ϩ progenitor cell type derived from monocytic cells. 7 Thus, cells used in many previous studies can be classified as CACs based on their characteristics and the isolation procedures. Unlike the later EPCs, CACs have a low proliferative capacity. Ex vivo CAC cultivation leads to rapid senescence onset, 8 and CAC senescence can also be accelerated by various atherogenic factors. 4, 9, 10 Delayed senescence onset is vital not only for neovascularization and arterial injury repair but also for the in vitro expansion and transplantation of CACs. However, whether and how HDL levels affect CAC senescence are poorly understood.
The serine/threonine protein kinase mammalian target of rapamycin (mTOR) critically regulates cellular survival, protein synthesis, cell growth, and proliferation. 11, 12 mTOR is also the key kinase involved in the regulation of human umbilical vein endothelial cell survival and hypoxia-induced arterial endothelial proliferation. 13, 14 Two functionally and structurally distinct mTOR-containing protein complexes, mTORC1 and mTORC2, have been identified, both of which contain phosphorylated mTOR as their central component. The mTORC1 complex composed of mTOR and raptor is highly sensitive to rapamycin, and phosphorylates p70-S6 kinase 1 to activate protein synthesis. Activation of mTORC1 by various stimulating factors, including insulin, primarily occurs though the phosphatidylinositol 3-kinase/Akt pathway. Therefore, mTORC1 plays a key role in insulin signaling and in maintaining metabolic homeostasis. Activated mTORC1 phosphorylates downstream targets (including p70 S6K on Thr389 and 4E-BP1 on Thr229) that regulate translational initiation, ribosome biogenesis, and other growth or proliferation events. 15, 16 The mTORC2 complex composed of mTOR, rictor, G-protein ␤-subunit like protein, and mammalian stress-activated protein kinase interacting protein 1. 17, 18 is regulated by growth factors, nutrient levels, and other factors. mTORC2 exerts effects on its downstream targets, including Akt, a protein kinase that mediates the telomerase activity and function of prosurvival genes and cell-cycle regulators. 19 -21 Indeed, mTORC2 exerts most of its cell-survival effects through its direct phosphorylation of Ser473 in the hydrophobic motif of Akt 19, 22 Although studies with acute exposure to rapamycin led researchers to initially conclude that mTORC2 is rapamycin insensitive, later studies have shown that longterm rapamycin exposure inhibits mTORC2 formation and blocks signal transduction through activated mTOR. 23 To date, the functional significance of mTOR signaling has not been well characterized in CACs. Therefore, the purpose of this study was to explore whether reconstituted HDL (rHDL) influences CAC senescence through the mTOR signaling pathway.
Materials and Methods
This section provides an abbreviated description of the Materials and Methods used in this study. A detailed description of all of the methods is provided in the Supplemental Materials and Methods, available online at http://atvb.ahajournals.org.
Reagents
rHDL was isolated and prepared from sera collected from young, healthy individuals, as described previously. 24 Monoclonal antibodies against phospho-Akt were from Santa Cruz Biotechnology. Unless otherwise noted, all other chemicals were from Sigma-Aldrich.
Cell Culture
CACs were prepared and cultured as previously described. 8, 25, 26 Briefly, total mononuclear cells were isolated by density gradient centrifugation from the peripheral blood of healthy volunteers. Immediately after isolation, mononuclear cells (4ϫ10 6 ) were plated onto human fibronectin-coated culture dishes. The cells were main- tained in endothelial cell basal medium-2 (Clontech) supplemented with vascular endothelial growth factor, basic fibroblast growth factor, insulin-like growth factor-1, epidermal growth factor, and 5% fetal calf serum. After 4 days in culture, nonadherent cells were removed by washing with PBS. Adherent cells that were positive for CD31, CD45, and vascular endothelial growth factor receptor 2 and that were capable of acetylated low-density lipoprotein uptake and Ulex europaeus agglutinin I binding were designated CACs.
Acidic ␤-Galactosidase Staining
Senescence-associated acidic ␤-galactosidase (␤-gal) staining was performed as previously described. 27 Cells were seeded with or without rHDL (10, 50, 100, or 150 g/mL) and were coincubated with rapamycin or Akt IV inhibitor for 7 days. Cells were fixed for 10 minutes in 2% formaldehyde and 0.2% glutaraldehyde in PBS and were incubated at 37°C for 12 hours with fresh ␤-gal solution.
Measurement of Mitochondrial Membrane Potential
To confirm the onset of cellular senescence using a second method, the electrochemical potential (⌬) of the CAC mitochondrial membrane was measured using confocal microscopy with the lipophilic cationic probe fluorochrome JC-1. 28 -30 In living cells, JC-1 accumulates in the mitochondria in a potential-dependent manner. At high membrane potentials, JC-1 forms J-aggregates (emission at 590 nm) and produces red fluorescence. At low membrane potentials, JC-1 continues to exist as a monomer (emission at 530 nm) and produces green fluorescence.
Western Blotting Analysis and Immunoprecipitation
Western blotting and immunoprecipitation were performed as previously described. 31
RNA Isolation, Telomerase Activity Assay, and Small Interfering RNA Transfection Techniques
Total RNA was extracted and purified using an RNeasy RNA extraction kit (Qiagen). Telomerase activity was measured using the Telo TAGGG Telomerase polymerase chain reaction ELISA plus kit (Roche). Rictor, raptor, and control small interfering RNAs (siRNAs) were transfected into CACs as described. 32 For a further description of these methods, please see the Supplemental Materials and Methods.
Animal Studies
Wild-type C57BL/6 male mice were obtained from the Experimental Animal Center of the China Academy of Medical Science/Peking Union Medical College. All experimental procedures and protocols were approved by the Committee for Animal Experiments of the China Academy of Medical Science/Peking Union Medical College and were performed in accordance with the Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996).
rHDL Treatment
To test whether rHDL directly protects CACs from senescence and improves CAC function in vivo, 16-to 18-month-old ("aged") male mice were treated with PBS alone (control) or with rHDL. The mice were injected intravenously with 0.3 mL of PBS (control) or 0.2 mg of apolipoprotein A-I in rHDL suspended in 0.3 mL of PBS (experimental), as described previously. 24
Isolation of CACs From Mouse Spleen
In addition to its role as a hematopoietic organ, the mouse spleen also functions as an important reservoir of CACs. 33, 34 Mononuclear cells were isolated from the spleen of aged mice, and CACs were isolated from these mononuclear cells as described above. The number of CACs was determined using the CAC culture assay, as described previously. 35 The senescence, telomerase activity, and mTOR and Akt phosphorylation levels of the CACs were detected using the methods described above. The CAC migration and adhesion activities also were assayed.
Statistical Analysis
Data are expressed as the meanϮSEM of Ն3 independent experiments. The Student t test was used to compare 2 groups. One-way ANOVA followed by the Tukey post hoc test was used to compare multiple groups. Statistical significance was defined at the PϽ0.05 level.
Results

Rapamycin Abolishes the rHDL-Induced Inhibition of CAC Senescence
Acidic ␤-gal serves as a biochemical marker for cellular senescence. Consistent with a previous study, 8 the CACs started to become senescent after 7 days of cultivation ( Figure  1A and 1B). This finding was confirmed by the ⌬ results ( Figure 1C and 1D). Treatment with 50, 100, or 150 g/mL rHDL reduced the number of acidic ␤-gal ϩ CACs ( Figure  1E ) and improved the ⌬ of CACs (data not shown). Coincubation with 1 or 5 nmol/L rapamycin abrogated the rHDL-mediated reduction in acidic ␤-gal ϩ CAC levels (Figure 1F ), suggesting that rHDL inhibits CAC senescence via the mTOR signaling pathway.
rHDL Promotes mTOR-Ser2448 Phosphorylation and mTOR Nuclear Translocation in CACs
The mTOR phosphorylation at Ser2448 and Ser2481 was observed in the presence or absence of rapamycin. Treatment with rHDL markedly increased mTOR phosphorylation at Ser2448 but not at Ser2481 (Figure 2A ). Ser2448 phosphorylation peaked at 4 hours and remained at a high level at 24 hours. Rapamycin reduced the active effect of rHDL on Ser2448 phosphorylation, but the total mTOR protein levels were not affected by rHDL ( Figure 2B ).
An additional regulatory mechanism of mTOR signaling may occur via cytoplasmic-nuclear shuttling. Therefore, we also examined whether rHDL influenced the nuclear localization of mTOR phosphorylated Ser2448. After CACs were cultured with rHDL for 4 hours, mTOR phosphorylated Ser2448 was observed in the nucleus fraction using Western blot. This nuclear localization was inhibited by rapamycin ( Figure 2C and 2D) . Immunohistochemistry showed a similar result (see Supplemental Results).
rHDL Induces mTORC2-Dependent Akt-Ser473 Phosphorylation
The phosphorylation of Akt at its primary phosphorylation site (Ser473) was analyzed during CAC incubation with rHDL for up to 24 hours. Akt-Ser473 phosphorylation increased after 10 minutes and peaked after Ϸ4 hours ( Figure 3A and 3B ), whereas the total Akt level remained unchanged. Rapamycin inhibited Akt phosphorylation starting at 4 hours, with inhibition increasing with longer incubation times ( Figure 3B ). When CACs were coincubated with rHDL and an Akt IV inhibitor, the Akt inhibition abrogated the rHDL inhibitory effect ( Figure 3C ). These results indicate that the rHDL-mediated inhibition of CAC senescence is mTOR/Akt dependent.
The roles of mTORC1 and mTORC2 in the inhibitory effect of rHDL on CAC senescence were analyzed. The mTORC2 complex is known to phosphorylate Akt at Ser473. To confirm whether rHDL induces mTORC2 formation in CACs, coexpression and association between mTOR and rictor were assessed in CACs treated with rHDL alone or cotreated with rapamycin. mTOR formed a complex with rictor in rHDL-treated CACs, whereas rapamycin inhibited the coprecipitation of both proteins ( Figure 4A ). Western blot analysis revealed that the rictor and raptor protein levels were consistently reduced (up to 85%) by CAC transfection with rictor-or raptor-specific siRNAs, respectively. Control siRNA had no effect ( Figure 4B ). The siRNA-treated CACs next were cocultured with rHDL for 4 hours. The siRNA-mediated suppression of rictor gene expression significantly decreased the rHDL-induced Akt phosphorylation compared with control siRNA transfection, whereas siRNA-mediated raptor suppression had no effect ( Figure 4C ). Suppression of rictor gene expression also abolished the inhibitory effect of rHDL on CAC senescence ( Figure 4D and 4E) .
Taken together, these findings suggest that rHDL stimulates mTOR-rictor complex formation and downstream Akt activation in CACs. Prolonged exposure of CACs to rapamycin inhibits Akt phosphorylation by inhibiting mTORC2, and rHDL prevents CAC senescence through the mTORC2/Akt signaling pathway.
rHDL Enhances the Nuclear Translocation of Human Telomerase Reverse Transcriptase and Nuclear Telomerase Activity in CACs Through the mTORC2/Akt Pathway
Cellular senescence is essentially influenced by telomerase activity, which is regulated at the human telomerase reverse (p-Akt) and total Akt (t-Akt) levels in total CAC lysates following incubation with rHDL (50 g/mL) without or with rapamycin (rapa; 1 nmol/L). B, Averaged densitometric quantification showing the ratio of phosphorylated Akt to total Akt protein levels with or without rapamycin (1 nmol/L). Akt-Ser473 phosphorylation increased after 10 minutes of incubation. Arb. indicates arbitrary. MeanϮSEM, nϭ4, *PϽ0.01 vs #. C, CACs were coincubated with rHDL (50 g/mL) and Akt IV inhibitor (AktI; 0.5, 1 or 5 mol/L). Inhibitory effect of rHDL on CAC senescence was abrogated by Akt IV inhibition. MeanϮSEM, nϭ6, *PϽ0.01 vs 50 g/mL rHDL and 0 mol/L AktI. transcriptase (hTERT) expression, phosphorylation, and nuclear translocation levels. To explore the mTROC2/Akt downstream mechanisms, we examined whether rHDL affected hTERT mRNA and protein expression in CACs using semiquantitative reverse transcription-polymerase chain reaction and Western blot ( Figure 5A ). Averaged densitometric quantification showed that the hTERT mRNA and protein levels in CACs were not changed significantly by rHDL (data not shown). We therefore explored whether rHDL-induced mTORC2 and Akt activation influenced hTERT nuclear translocation in CACs. Nuclear accumulation of hTERT ( Figure 5B ) and nuclear telomerase activity ( Figure 5E ) in CACs were promoted by rHDL. These effects were blocked by rapamycin, by Akt IV inhibitor, and by siRNA-mediated suppression of rictor gene expression ( Figure  6C to 6E).
Treatment With rHDL Reduces CAC Senescence and Increases CAC Number in the Spleen of Aged Mice
To study whether rHDL can affect CAC senescence in vivo, we measured the senescence of CACs isolated from the spleen of aged (16 to 18 months) and young (2 to 3 months) mice. In aged mice, the percentage of splenic senescent cells was Ϸ3-fold higher and the number of splenic CACs was reduced by Ϸ0.4-fold compared with young mice ( Figure  6A ). Treatment of aged mice with rHDL for 6 days reduced the CAC senescence to 11.5Ϯ3.7% (control, 22.8Ϯ4.9%) and increased the number of CACs to 76Ϯ10.8 cells/high-power field compared with mice treated with PBS (53Ϯ6.7 cells/ high-power field) ( Figure 6B and 6C) .
To further explore the effect of rHDL on CACs in vivo, phosphorylated mTOR and Akt levels were detected and the nuclear telomerase activity was measured. Treatment with rHDL significantly enhanced the phosphorylation levels of mTOR and Akt and the nuclear telomerase activity in CACs isolated from aged mice ( Figure 6D and  6E) . The migratory capacity ( Figure 6F ) and adhesion activity ( Figure 6G ) of CACs isolated from rHDL-treated aged mice (67.0Ϯ5.1 and 43.8Ϯ7.3 cells/high-power field, respectively) were improved significantly compared with mice 
Discussion
We showed here that rHDL inhibits the onset of CAC senescence by promoting sustained mTOR phosphorylation, mTORC-rictor complex formation, and mTORC2-dependent Akt phosphorylation. Furthermore, mTORC2-mediated Akt activation enhances the nuclear translocation of hTERT and nuclear telomerase activity in CACs. These findings reveal important mechanistic clues in understanding the effect of HDL on CACs.
The antiatherosclerotic actions of HDL 36 are generally attributed to its uptake of cellular cholesterol from the periphery and its transport of excess cholesterol to the liver. Recently, HDL was shown to have multiple direct effects on EPCs that may be critical for atheroprotection. For example, HDL increases the number of EPCs, perhaps by prolonging their survival period or preventing senescence. 6, 37 Other effects include enhancing progenitor-mediated endothelium repair in mice, 38 promoting the differentiation of mononuclear cells/EPCs into endothelial-like cells, and enhancing ischemia-induced angiogenesis. Low plasma HDL levels clinically are associated with impaired endothelial function and a decreased number of EPCs. 39 Increasing the HDL level in patients with type 2 diabetes by systemic rHDL infusion can improve the availability of CD34 ϩ vascular endothelial growth factor receptor 2 ϩ -cells (which may containing CACs). 40 It is widely accepted that CACs and EPCs collaboratively participate in angiogenesis and arterial repair. Furthermore, the improvement of CAC function is very important for neovascularization and antiatherogenesis. However, little is known about the molecular mechanisms by which HDL regulates CAC function. We observed that rHDL potently delayed senescence onset in CACs through a mechanism involving mTOR activation. mTOR activity is regulated by phosphorylation at Ser2448 or autophosphorylation at 2481. 11 In this study, rHDL appeared to activate mTOR signaling by promoting a rapid and sustained high-level phosphorylation of mTOR Ser2448 but not Ser2481. In terms of whether rHDL activates Akt through activated mTOR, we observed that rHDL increased and maintained a high level of Akt-Ser473 phosphorylation. Incubation of CACs with rapamycin for Ͼ4 hours inhibited mTOR-Ser2448 phosphorylation and completely attenuated Akt-Ser473 phosphorylation. Inhibiting Akt with a special inhibitor also abrogated the rHDL inhibitory effect on CAC senescence. mTORC1 formation is increased in vascular endothelial cells mainly during the early stage of cell stimulation (eg, hypoxic state for Ͻ3 hours), whereas mTORC2 formation is delayed. 14 We observed that mTORC2 formation was increased but mTORC1 was nearly undetectable after CACs were incubated with rHDL for 240 minutes. Rapamycin blocked mTOR-rictor complex formation and simultaneously abolished rHDL-induced Akt phosphorylation after 240 minutes. This siRNA-mediated rictor silencing not only decreased rHDL-induced Akt phosphorylation but also abolished senescence inhibition by rHDL. In contrast, raptor silencing had no effect. Thus, prolonged incubation with rHDL can stimulate Akt activation by inducing mTOR phosphorylation and mTORC2 complex formation in CACs, and rHDL inhibits CAC senescence through the mTORC2/ Akt pathway. Determination of whether rHDL can enhance mTORC1 formation in CACs at the early stage (Ͻ4 hours) of incubation requires further investigation.
The proatherosclerosis factors oxidized low-density lipoprotein, angiotensin II, and homocysteine reportedly accelerate CAC senescence onset by inactivating telomerase activity. 9, 41, 42 Conversely, estrogen and resveratrol reduce CACs senescence by augmenting telomerase activity. 43, 44 The overexpression of hTERT by adenovirus-mediated gene delivery also delays CACs senescence. 45 We observed that rHDL had no effect on the hTERT mRNA or protein level in CACs, suggesting that rHDL did not regulate telomerase activity at the hTERT-expression level. Because telomerase activity also can be positively regulated by Akt-mediated phosphorylation and hTERT nuclear translocation, 46, 47 we explored whether rHDL-induced mTORC2/Akt activation influences hTERT nuclear translocation. rHDL promoted hTERT accumulation in the nucleus, significantly increasing the nuclear telomerase activity of CACs. This effect was blocked by rapamycin and the Akt IV inhibitor, as well as by the suppression of rictor gene expression. These results suggest that rHDL increases the nuclear telomerase activity in CACs through mTORC2 and AKt activation. Because Akt also regulates endothelial nitric oxide synthase activity and some cell cycle regulators and cell survival pathways, other mechanisms may contribute to the inhibitory effect of rHDL on CAC senescence.
To study whether rHDL has an effect on CACs in vivo, we measured the senescence of CACs isolated from the spleens of aged and young mice. Compared with the young mice, the aged mice displayed a higher percentage of senescent cells and significantly fewer isolated CACs. Treatment of aged mice with rHDL for 3 days did not affect CAC senescence, although rHDL treatment for 6 days attenuated CAC senescence and significantly increased the number of CACs compared with PBS-treated mice. In CACs isolated from rHDL-treated aged mice, the phosphorylated mTOR and Akt levels and telomerase activity were significantly enhanced. Consistently, functional activity assays showed that the mi- gratory capacity and adhesion activity of CACs isolated from rHDL-treated aged mice were significantly improved. These results indicate that rHDL administration inhibits CAC senescence and improves CAC activity in vivo.
In conclusion, rHDL was shown to stimulate mTOR phosphorylation, mTORC2 formation, and downstream Akt activation in CACs and to inhibit CACs senescence onset through mTORC2/Akt-mediated enhancement of nuclear telomerase activity. These results implicate novel mechanisms by which rHDL protects the function of CACs, and they indicate mTORC2 as an important mediator of CAC viability.
